. Using in vitro models of hPGC induction [2][3][4] , recent studies have suggested that there are marked mechanistic differences in the specification of human and mouse PGCs
. This may be due in part to the divergence in their pluripotency networks and early post-implantation development 6-8 . As early human embryos are not accessible for direct study, we considered alternatives including porcine embryos that, as in humans, develop as bilaminar embryonic discs. Here we show that porcine PGCs originate from the posterior pre-primitive-streak competent epiblast by sequential upregulation of SOX17 and BLIMP1 in response to WNT and BMP signalling. We use this model together with human and monkey in vitro models simulating peri-gastrulation development to show the conserved principles of epiblast development for competency for primordial germ cell fate. This process is followed by initiation of the epigenetic program 9-11 and regulated by a balanced SOX17-BLIMP1 gene dosage. Our combinatorial approach using human, porcine and monkey in vivo and in vitro models provides synthetic insights into early human development.
We first determined the origin of porcine PGCs (pPGCs) in peri-gastrulating embryos at embryonic days 9.5-16 (E9.5-E16). At around E9.5-E10, key pluripotency markers NANOG, OCT4 and SOX2 are detected in the epiblast of bilaminar embryos (Fig. 1a) . In E11 pre-primitive-streak (pre-PS)-stage embryos with an incipient anterior-posterior axis (Extended Data Fig. 1a) , BRACHYURY (also known as T) expression is evident in the posterior pseudo-stratified epiblast cells, together with NANOG and OCT4, but SOX2 is downregulated (Fig. 1b) .
In the midline of early-PS-stage embryos (~ E11.5-E12), we detected the first cluster of SOX17 + cells in the posterior end of the nascent primitive streak (Fig. 1c, d , Extended Data Fig. 1b) ; most of these express BLIMP1, except for those at the anterior end (arrows in Fig.1c, d ). Expression of SOX17 precedes BLIMP1, and NANOG is upregulated in SOX17 +
BLIMP1
+ pPGCs (Fig. 1d , Extended Data Fig. 1b) . In embryos at E12.5-E13.5, pPGCs exhibit co-expression of SOX17, BLIMP1, NANOG, TFAP2C, OCT4, and the pPGC cell surface marker Sda/GM2 (ref. 12), but have low levels of T expression (Fig. 1e, Extended Data Fig. 1c, d ). This pPGC cluster of around 60 SOX17 +
+ cells, located at the border between embryonic and extra-embryonic tissues in early-PS-stage embryos (~ E12), increases to more than 300 pPGCs by E15.5 (Extended Data Fig. 2a-c) . A six-hour pulse of EdU labelling shows that DNA synthesis ceases soon after detection of the Sda/GM2 epitope (Fig. 1f , Extended Data Fig.2d ), indicating that the sharp increase in pPGCs is probably due to the additional recruitment from T + competent progenitors. Thereafter, pPGCs enter quiescence and pause prior to migration, as in mice 13 ( Fig. 1f , Extended Data Fig. 2c) . Notably, PRDM14 expression in pPGCs is weak and apparently cytoplasmic (Extended Data Fig. 1f ), whereas SOX2 is undetectable (Extended Data Fig. 2e, f) . Initiation of the germline-specific epigenetic program 9,14 is evident in nascent pPGCs with a global reduction in 5-methylcytosine (Extended Data Fig. 3b , c) and concomitant enrichment of 5-hydroxymethylcytosine (5hmC) (Fig. 1g, h ). Consistently, UHRF1 is downregulated ( Fig. 1i ) and TET1 is upregulated (Extended Data Fig. 3a ). Progressive reduction in H3K9me2 and G9A (also known as EHMT2) expression was also evident (Extended Data Fig. 3b , c) and global DNA demethylation followed as pPGCs migrate towards the gonads (Extended Data  Fig. 3d ). pPGCs continued to express SOX17, BLIMP1, TFAP2C, OCT4 and NANOG (arrowheads in Fig. 1e , Extended Data Fig. 2e, f) , as seen in equivalent hPGCs in vivo 4, 9 . Thus, pPGCs originating from the peri-gastrulation porcine epiblast exhibited close similarities with hPGCs following sequential SOX17 and BLIMP1 expression, and the onset of the epigenetic program 4, 9 . To determine when porcine epiblasts gain competency for pPGC fate, we isolated epiblast discs from the hypoblast and trophectoderm at different stages of development (Fig. 2a, b, d , e). We exposed them to cytokines, including either BMP2 or BMP4 (refs 2-5) (hereafter referred to as cytokines), for 64 h to induce pPGCs ex vivo (Fig. 2f) . Although no response was seen in E10.5-E11 early bilaminar disc epiblasts, an efficient induction of pPGCs occurs in epiblasts from E11.5 pre-PS embryos, with co-expression of SOX17, BLIMP1, NANOG, OCT4 and TFAP2C (Fig. 2g , h, Extended Data Fig. 3e ). Notably, we detected a strong BMP2/4 signal from the posterior pre-PS and early-PS pig embryos in vivo 15, 16 (Fig. 2a) , with nuclear pSMAD1/5/8 localization in the posterior epiblast (Fig. 2c) . BMP inhibitor (BMPi) abrogates pPGC induction (Fig. 2g, Extended Data Fig. 3e ). The competency for pPGC fate wanes during early-PS-stage concomitantly with the onset of gastrulation and mesendoderm differentiation (Fig. 1c) . WNT signalling from the posterior pre-PS epiblast is also important 16 (Fig. 2a) , as evidenced by the high proportion of T + cells, a downstream target of WNT 17 , during pPGC induction (Fig. 1b) . A WNT inhibitor (WNTi) diminished pPGC induction, but not in early-PS-stage epiblasts when they were already competent for pPGC fate (Fig. 2g, Extended Data Fig. 3e ). Expression of T in response to WNT is a common feature of competency for germ cell fate 3,4,17 . As we cannot examine early human embryos directly, we simulated human peri-gastrulation development and induced hPGC fate in vitro. We established an in vitro model with human pluripotent stem cells (hPSCs) for mesendoderm and peri-gastrulation development [18] [19] [20] ( Fig. 3a) . These hPSCs in a defined conventional medium (hereafter denoted as conv-hPSCs, see Methods) are probably equivalent to the pre-gastrulating porcine epiblast 21 . To follow gain and loss of competency for hPGC specification over the course of mesendoderm differentiation, we used cells with a sensitive NANOS3-tdTomato reporter (see Extended Data Fig. 4) . By checking for induction of hPGCs by cytokines at 6 h intervals (Fig. 3a) , we observed a peak of competency at around 12 h during mesendoderm differentiation, declining thereafter (Fig. 3b, d) , illustrating a step-wise transition in cell states. PGCcompetent cells showed moderate upregulation of primitive-streak 
SOX17
+ BLIMP + cells. Scale bar, 10 μ m. Inset shows the whole embryo. e, Late primitive streak embryo (late-PS; ~ E12.5-E13.5) with a pPGC cluster (arrow) showing NANOG, SOX17, TFAP2C, BLIMP1, T and Sda/ GM2 expression. Arrowheads, early migratory pPGCs. Scale bar, 25 μ m. A-P, anterior-posterior axis. f, Quantification of EdU incorporation in pPGCs and somatic cells. Numbers denote analysed cells (error bars, mean ± s.e.m.). g, Sagittal section of E14.5 embryo immunostained for OCT4 and 5hmC, and the pPGC cluster (white square on the right). Arrows, migratory PGCs. Scale bar, 20 μ m. h, Quantifi cation of 5hmC in analysed cells (boxes, mean and interquartile ranges; whiskers, maximum and minimum; Mann-Whitney U-test, *P < 0.01). i, Immuno staining for UHRF1 in E14 embryos. Dashed line delimits the pPGC cluster. Scale bar, 20 μ m. markers T, MIXL, GSC, EVX1 and EOMES, and a slight reduction of SOX2 (Fig. 3e, Extended Data Fig. 5a, b) . From 18 h onwards, there was upregulation of late primitive-streak markers TBX6, MESP1/2, and SNAI1/2, which trigger epithelial-mesenchymal transition, occurring during gastrulation 22 (Extended Data Fig. 5b ). The response of cells to signalling also changes, as BMP2/4 now induces mesodermal cells (Extended Data Fig. 5b , e-h), whereas activin A and a BMP inhibitor efficiently induce definitive endoderm 18 (Fig. 3c, d . Extended Data Fig. 5e-h ). Thus, from around 12 h onwards, the mesendoderm precursors (pre-ME) are competent for PGC fate, but from around 18 h (mesendoderm), competency for PGC declined, with concomitant gain of competency for definitive endoderm and/or mesoderm fates (Fig. 3a-c) .
Both WNT and ACTIVIN/NODAL signalling are necessary for competency for hPGCs in 12 h pre-ME (Extended Data Fig. 5c ). Inhibition of BMP during mesendoderm differentiation markedly reduced the efficiency of hPGC induction, suggesting a role for endogenous BMP (Extended Data Fig. 5d ). Addition of BMP during pre-ME (12 h), however, does not affect hPGC competency, but favours differentiation into lateral mesoderm at 24 h, which originates from the mid/ posterior primitive streak (Extended Data Fig. 5e-h ). By contrast, definitive endoderm differentiation occurs in the anterior primitive streak, as seen in primitive-streak-stage porcine embryos (arrowheads in Fig. 1d , Extended Data Fig.1c ), suggesting that BMP confers posterior characteristics to the primitive streak during gastrulation (Extended Data Fig. 5i ). The combined evidence from porcine embryos, and simulations in vitro with conv-hPSCs, shows progressive and transient acquisition of competency for hPGC, followed by competency for definitive endoderm and/or mesoderm.
To test whether this model applies to non-human primates, we used cynomolgus monkey PSCs (cmPSCs) to induce mesendoderm differentiation (Extended Data Fig. 6a, b) . Remarkably, cmPSCs also showed a temporal gain of competency for cmPGC fate at around 12 h during mesendoderm differentiation, and thereafter definitive endoderm and mesoderm at 24 h (Extended Data Fig. 6c-f) . A recent study suggested + AP + cells) from pre-ME (12 h) or mesendoderm (24 h). Pre-ME are competent for hPGCs in response to cytokines or SOX17, but mesendoderm is not. g, Immunostaining of day 4 embryoids from pre-ME (12 h) or mesendoderm (24 h). SOX17 in pre-ME induced OCT4 + BLIMP1 + hPGCs (dashed line), but in mesendoderm, it induced definitive endoderm (BLIMP1 + FOXA2 + ) cells. Scale bar, 50 μ m.
letter reSeArCH that cmPGCs originate from the epiblast-derived nascent amnion, but also potentially from the posterior epiblast 23 ; a dual origin is, however, also possible. A detailed molecular analysis of amnion is important, as SOX17 and BLIMP1 also have roles elsewhere, including extraembryonic tissues 24, 25 , which exhibit great developmental diversity and less developmental constraint than epiblasts 26 . Further traceable analysis of in vivo non-human primate embryos and potentially of human embryos in vitro is merited.
We next examined the combinatorial roles of key transcription factors, considering that SOX17 is the key regulator of both hPGCs and definitive endoderm 4,27 (Fig. 3d) . Ectopic expression of SOX17 in pre-ME at 12 h induces hPGCs, resulting in NANOS3-tdTomato
+ cells, but in mesendoderm at 24 h it induces FOXA2 + (definitive endoderm) efficiently (Fig. 3f, g ). During the induction of hPGCs in pre-ME by BMP (Extended Data  Fig. 7a, b) , we first detected SOX17 at 12 h, and around 30-40% of the cells also expressed BLIMP1 but not TFAP2C (Extended Data . PRDM14 is critical for PGC fate and epigenetic reprogramming in mice 29 , but its role, if any, in hPGCs and pPGCs requires further studies.
We next tested the roles of SOX17, BLIMP1 and TFAP2C individually and in combination in the induction of hPGCs in the self-renewing PGC-competent hPSCs (comp-hPSCs) 4 , using a NANOS3-tdTomato reporter and inducible SOX17, BLIMP1 and TFAP2C transgenes (Extended Data Figs 4c-j, 8d-g, see Methods). BLIMP1 and TFAP2C individually and together elicit a negligible response after 2 days, whereas SOX17 alone produces a modest response, with or without SRY  SOX9  WT1  EMX2  LHX9  CDX2  EOMES  TEAD4  GBX2  FGF5  OTX2*  PAX6  ASCL1  KDR  PDGFRA  GATA2  HAND1  T  HNF4A  HNF1A  FOXA2  FOXA1*  GATA6  GATA4  PIWIL4  PIWIL2  PIWIL1  TDRD10  TDRD9  TDRD5  RNF17  MAEL  DDX4  DAZL  SYCP3 (Fig. 4a) . Notably, SOX17 and BLIMP1 together produce a strong response and a large proportion of NANOS3-tdTomato + cells (Fig. 4a) , suggesting that they act synergistically and rapidly (within around 24 h), compared to the 96 h taken for cytokines to induce a similar response (Fig. 4b, c) . This response is preceded by downregulation of SOX2 (ref. 30) and upregulation of 'naive' pluripotency genes including KLF4 and TFCP2L1, as in hPGCs in vivo 9 (Fig. 4e, Extended  Data Fig. 8h) . The response to SOX17-BLIMP1 is otherwise similar to that induced by cytokines, as determined by global RNA-sequencing (RNA-seq) (Fig. 4d, Extended Data Fig. 8i, j) .
For further mechanistic insights, we induced ectopic SOX17 with or without BLIMP1 expression in SOX17-null comp-hPSCs 4 (Extended Data Figs 9a, 10a, b) . Although SOX17 initiates hPGC fate, there is also a significant increase in expression of FOXA2, an endodermal gene (Fig. 4f) . Accordingly, FACS-purified cells show FOXA1, FOXA2 and HNF1β expression, as well as PGC markers OCT4, NANOG, BLIMP1 and TFAP2C (Extended Data Fig. 9b ), and the cell surface marker CXCR4 that is expressed by both endoderm 19 and PGCs in humans (Extended Data Fig. 9c, d ). This probably occurs owing to high ectopic SOX17 gene dosage exceeding the levels induced by BMP in wild-type comp-hPSCs (Extended Data Fig. 9b , e-h), without a proportionate increase in BLIMP1 (Extended Data Fig. 9i) . Notably, BLIMP1 represses endodermal genes during hPGC specification 9 . Indeed, concomitantly high BLIMP1 and SOX17 induce hPGCs robustly and rapidly, while suppressing endoderm genes (Fig. 4g, Extended Data Fig. 10c) , and also initiate the germline-specific epigenetic program 9 , with downregulation of DNMT3A, DNMT3B and UHRF1, and upregulation of TET2 (Extended Data Fig. 8k ), as in pPGCs (Fig. 1g-i , Extended Data Fig. 3a-d) .
The ex vivo peri-gastrulation porcine embryos, and in vitro mimics for human and monkey development exemplify conserved principles for PGC specification in the context of epiblast development in flat disc embryos (Fig. 4h) . We show that SOX17 probably regulates both PGCs and definitive endoderm. We also propose that signalling, followed by epigenetic priming of regulatory elements, might confer competency for PGC fate, and thereafter definitive endoderm and/or mesoderm, as an integral part of epiblast development program towards gastrulation. SOX17 and BLIMP1 are necessary and sufficient for inducing PGCs, and for initiating the germline-specific epigenetic program. Once specified, PGCs are irreversibly committed to the germline fate (Extended Data Figs 2e, f, 10d, e) . Notably, our integrated approach provides insights into early human development and cell fate decisions.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Immunohistochemistry of porcine embryos and gonads. Embryos (embryonic day (E) 10-16; bilaminar (n = 4); pre-PS (n = 7), early-PS (n = 6); primitive streak (n = 10), late-PS (n = 13), E14 (n = 8), E16 (n = 10)) were processed as previously described 15, 31 . Briefly, embryos and gonads were fixed in 2.5% paraformaldehyde (PFA) in PBS overnight at 4 °C and transferred to methanol at − 20 °C for long term storage. For less advanced embryos (E9.5-10.5) 2% agarose blocks were made before embedding in wax. Agarose blocks were then trimmed and dehydrated with increasing concentrations of ethanol (70%, 90% and 100%) for 2 h each step. After dehydration, blocks were processed in xylene followed by hot paraffin wax for 2 h and then cooled down in a metal mould. E14-15 embryos and gonads were dehydrated, embedded and processed as described above. All paraffin blocks were cut into 4-μ m-thick sections and mounted onto SuperFrost plus slides. Sections were air-dried overnight and immunohistochemistry was conducted subsequently. For cryo-sections, fixed embryos were incubated in 30% sucrose/PBS overnight at 4 °C prior to mounting in OCT compound. Cryo-sections were cut at 6 μ m onto Superfrost plus glass slides. Sections were left to air dry for 1-2 h before immunofluorescence. Unused slides were kept at − 80 °C in air-tight containers. Immunofluorescence staining of porcine embryos. Sections were dewaxed with xylene for 30 min and rehydrated with decreasing concentrations of ethanol (100%, 90% and 70%) and transferred to PBS for 15 min. Antigen retrieval was then performed by boiling the slides in 0.01 M citrate buffer (pH 6.0) for 10 min. Sections were permeabilized with 1% Triton X-100 in PBS for 15 min. Triton X-100 was washed three times for 5 min each, and blocking solution (PBS supplemented with 5% BSA or 10% donkey serum/5% BSA/PBS) was added for 1-1.5 h. After blocking, sections were incubated with the desired primary antibody (see Supplementary  Table 2 ) overnight at 4 °C in a humidified chamber. Slides were then washed three times with 0.1% Tween-20/PBS. Finally slides were incubated with fluorescent (TRITC, Cy3 Alexa fluorophore 488, 555, 568 and/or 647; eBioscience, Abcam, Thermo Fisher Scientific)-conjugated secondary antibodies for 40 min at room temperature. Slides were mounted with Fluoroshield with DAPI (Sigma) and sealed with nail varnish. Slides were kept at − 20 °C until observed. Porcine epiblast cultures and quantification of PGC induction. Embryos collected 11.5 days after artificial insemination were dissected under a dissecting microscope as described previously 31 . Trophectoderm and primitive endoderm were carefully removed with forceps and pure epiblasts were pre-incubated in GK15 medium supplemented with individual inhibitors, including 10 μ M WNTi (IWR-1-endo, Selleckchem), and 100 nM BMPi (LDN193189, Sigma). GK15 medium is composed of GMEM (Thermo Fisher Scientific) supplemented with 15% KSR, 0.1 mM 2-mercaptoethanol (Thermo Fisher Scientific), 0.1 mM NEAA (Thermo Fisher Scientific), 1 mM sodium pyruvate (Sigma), 100 U ml −1 penicillin, 0.1 mg ml −1 streptomycin (Sigma), and 2 mM l-glutamine (Sigma). After 30 min incubation with the inhibitors, cytokines were supplemented to the final concentration of 500 ng ml −1 BMP4 (R&D systems), 1 mg ml −1 hLIF (Peprotech) and 200 ng ml −1 SCF (R&D systems). Epiblasts collected from two independent batches of animals and from four animals each time were grouped by stage of development (bilaminar, pre-PS, early-PS) and randomly distributed into three treatment groups. After 64 h incubation in a low oxygen incubator at 38.5 ºC, they were fixed in 2.5% PFA at 4 °C overnight. After washing in PBS they were incubated in 30% sucrose/0.0025% sodium azide at 4 °C overnight and then mounted in OCT compound as described above. Immunofluorescence was carried out with the antibodies listed in Supplementary Table 2 with fluorescenceconjugated secondary antibodies.
All immunostained sections of single epiblasts were imaged at 100× magnification at antibody-specific wavelengths. NANOG + cells could be split into two categories; high expression and lower expression, based on immunofluorescence intensity. Image acquisition was performed using SimplePCI capture software and the Cell Counter application of Fiji was used to mark protein of interest and NANOG hi cells. Separate fluorophore images were overlaid and cells marked as positive for all three proteins of interest were counted. Only robustly stained cells were considered positive. No statistical methods were used to predetermine sample size. Mann-Whitney U-test was used to test for significance. Whole-mount in situ hybridization. RNA in situ hybridization (ISH) was carried out as previously described 15 . Briefly, embryos (neural plate (n = 2); 3-5 somites (n = 3); 6-8 somites (n = 3)) were rehydrated in decreasing concentrations of methanol and then washed in PBS-T (PBS + 0.1% Tween-20). Next, embryos were equilibrated in (1:1) PBST-hybridization buffer (formamide: 50%, 2× SSC (pH 5), EDTA (5 mM, pH 8), 0.05 mg ml −1 yeast RNA, 0.2% Tween-20, 0.5% CHAPS, 0.1 mg ml −1 heparin) for at least 10 min, and then transferred to hybridization buffer before incubating at hybridization temperature for a minimum of 2 h. After incubation, hybridization buffer containing pig OCT4 probe was added and incubated overnight. The following day the probe was removed and embryos were washed 3-5 times with wash buffer (50% formamide, 1× SSC (pH 5), 0.1% Tween-20) at hybridization temperature, and then equilibrated with (1:1) wash buffer and MABT solution (MABT solution: 100 mM maleic acid, 150 mM NaCl, 0.005% Tween-20) before washing with MABT solution at room temperature. The embryos were then blocked with MABT and of 2% blocking reagent (Roche) for 1 h followed by blocking solution with MABT, 2% blocking reagent and 10% normal goat serum for at least 2 h. The blocking solution was then replaced with a 1:2,000 dilution of anti-Dig-AP Fab fragments (Roche) and incubated overnight with gentle agitation at 4°C. Embryos were rinsed in MABT several times before the development step with NBT/BCIP. After colour reaction embryos were washed with 5× TBST (TBST: 0.7 M NaCl, 0.01 M KCl, 0.125 M Tris (pH 7.5), 0.5% Tween-20) solution. The colour reaction was repeated until signal was detected. Once the colour reaction was satisfactory, the embryos were re-fixed with 4% PFA for 1 h, rinsed in PBST and observed under a microscope. EdU labelling. Collected embryos (n = 7) were rinsed in wash medium before 6 h incubation in 10 uM EdU at 38.5°C. After rinsing, the embryos were fixed in 4% PFA for 2 h and then transferred to 1% PFA for long-term storage. Embryos were processed for immunohistochemistry as described above, except that the EdU staining protocol was performed following manufacturer instruction (Click-iT EdU, Invitrogen) prior to addition of primary antibodies used for co-labelling. Cell culture. NANOS3-mCherry hPSCs, SOX17-knockout hPSCs, SOX17-knockout + inducible SOX17 (iS) hPSCs lines were established previously 4 . NANOS3-tdTomato hPSC line was newly generated by gene targeting (see 'Vector construction and gene introduction'). A cynomolgus monkey PSC (cmPSC) line (MF12 embryonic stem cells (ESCs)) was from E. Curnow, Washington National Primate Research Centre. All cell lines were confirmed as mycoplasma negative.
Undifferentiated conv-hPSCs were maintained on vitronectin-coated plates in Essential 8 medium 32 (Thermo Fisher Scientific) according to manufacturer's protocol. Cells were passed every 3-5 days using 0.5 mM EDTA/PBS without breaking cell clumps.
Undifferentiated comp-hPSCs were maintained on mitomycin-C treated or irradiated mouse embryonic fibroblast (MEF) (purchased from MTI-GlobalStem or prepared in house) in knockout DMEM (Thermo Fisher Scientific) supplemented with 20% KSR, 0.1 mM NEAA, 0.1 mM 2-mercaptoethanol, 100 U ml −1 penicillin, 0.1 mg ml −1 streptomycin, 2 mM l-glutamine, 20 ng ml −1 human LIF (Stem Cell Institute, University of Cambridge (SCI)), 8 ng ml −1 bFGF (SCI), 1 ng ml . Cells were passed every 2-4 days using TrypLE express or 0.25% trypsin/EDTA (Thermo Fisher Scientific). Before harvesting comp-PSCs on MEF, 10 μ M of ROCKi (Y-27632, Tocris bioscience) was added to the medium.
Undifferentiated cmPSC were maintained on mitomycin-C treated or irradiated MEF in DMEM/F-12 (Thermo Fisher Scientific) supplemented with 20% KSR, 0.1 mM NEAA, 0.1 mM 2-mercaptoethanol, 100 U ml −1 penicillin, 0.1 mg ml
streptomycin, 2 mM l-glutamine, 20 ng ml −1 bFGF (SCI). Before differentiation, cmPSC were maintained on MEF in Essential 8 medium supplemented with 5% KSR, 2.5 μ M WNTi (IWR-1; Tocris) at least for 2 passages. Cells were passed every 3-4 days using 0.25% trypsin/EDTA (Thermo Fisher Scientific). Before harvesting cmPSC on MEF, 10 μ M of ROCKi (Y-27632, Tocris bioscience) was added to the medium.
For mesendoderm induction and subsequent definitive endoderm or lateral mesoderm induction, we optimized published protocols 18,34,35 with slight modifications. For the basal medium, we used aRB27 medium which is composed of Advanced RPMI 1640 Medium (Thermo Fisher Scientific) supplemented with 1% B27 supplement (Thermo Fisher Scientific), 0.1 mM NEAA, 100 U ml −1 penicillin, 0.1 mg ml −1 streptomycin, 2 mM l-glutamine. For mesendoderm induction, trypsinized conv-hPSCs were seeded on vitronectin-coated dish at 200,000 cells letter reSeArCH per well in 12-well plate and cultured in mesendoderm induction medium for 6-36 h as indicated in the figures. Mesendoderm induction medium contained aRB27 medium supplemented with 100 ng ml −1 activin A (SCI), 3 μ M GSK3i and 10 μ M of ROCKi. For definitive endoderm induction, mesendoderm induction medium was replaced with definitive endoderm induction medium after washing with PBS once and cells were cultured for further 2-3 days. Definitive endoderm induction medium was composed of aRB27 medium supplemented with 100 ng ml −1 activin A and 0.5 μ M BMPi (Sigma). For lateral mesoderm induction, mesendoderm induction medium was replaced with lateral mesoderm induction medium after washing with PBS once and cells were cultured for further 1 day. Lateral mesoderm induction medium was composed of aRB27 medium supplemented with 100 ng ml −1 BMP2 (SCI), 2.5 μ M WNTi (IWR-1) and 10 μ M TGFβi (SB 431542; Tocris).
Embryoids were formed according to a previous report 4 . Briefly, conv-or comp-hPSCs, pre-ME or mesendoderm were trypsinized into single cells and harvested into Corning Costar Ultra-Low attachment multiwell 96-well plate (Sigma) or PrimeSurface 96V plate (S-BIO) at 4,000 cells per well in GK15 medium or aRB27 medium. To improve the cell aggregation, in some experiments, we added 0.25% (v/v) poly-vinyl alcohol (Sigma) in the basal medium, according to published protocol 36 . For hPGC induction with cytokines, 500 ng ml −1 BMP4 or BMP2 (SCI), 10 ng ml −1 human LIF (SCI), 100 ng ml −1 SCF, 50 ng ml −1 EGF (R&D Systems), and 10 μ M ROCKi were added to GK15 medium or aRB27 medium. Notably, use of aRB27 medium for the basal medium improved the efficiency of hPGC induction, especially, when we used pre-ME cells (see Extended Data Fig. 4i, j) . A detailed protocol of the in vitro differentiation system described above is also available at Protocol Exchange 37 . For induction of exogenous transgenes, 100 μ M dexamethasone (Sigma), 0.5 μ g ml −1 doxycycline (Sigma) and/or 0.5 μ M Shiled-1 (Clontech) were added to the medium. Vector construction and gene introduction. For construction of NANOS3-tdTomato knock-in targeting vector, 5′ and 3′ arms amplified from NANOS3-mCherry knock-in targeting vector 4 , rox-PGK-PuroΔtk-rox amplified from pL1L2-PGKpuroΔ tk (a gift from S.C.I.), MC1-promoter driven DTA cassette amplified from pMC1-DTA, were cloned into pBluescript KS(+ ) (Stratagene) with an in-fusion HD cloning kit (Takara Bio). For efficient gene targeting, we used the CRISPR-Cas9 system. Guide RNAs targeting around the stop codon sequence of NANOS3 genes (5′ -caccgAGCCTCCTAGGTGGACATGG-3′ , 5′ -aaacCCA TGTCCACCTAGGAGGCTc-3′ ) were cloned into pX330 (Addgene) or eSpCas9(1.1) (Addgene). For construction of pCAG-Dre-IRES-Hygromycinr, puromycin resistance gene in pCAGGS-Dre-IRES-Puror was replaced with hygromycin resistance gene. For construction of dox/Shiled-1 inducible system, SOX17 cDNA without stop codon amplified from cDNA of hPGC and destabilized-domain amplified from pBMN YFP-FKBP (Addgene) were cloned into PiggyBAC vector used previously 38 . For construction of dox-inducible system, Tet3G amplified from pCMV-Tet3G (Clonetech) was cloned into PiggyBAC vector which contains CAG-promoter and IRES-neomycin-resistance gene. TRE3G cassette amplified from pTRE3G (Clonetech), human BLIMP1 cDNA amplified from TRE-Tight BLIMP1-EGFP 38 , human NANOG cDNA amplified from pEP4-E02S-CK2M-EN2L (Addgene) and human TFAP2C cDNA amplified from hPGC were cloned into PiggyBAC vector. All fragments were amplified by PCR using PrimeSTAR MAX or PrimeSTAR GXL DNA polymerase (Takara Bio) according to the manufacturer's protocol.
For gene targeting of NANOS3-tdTomato reporter, WIS2 male hESC and H9 female hESC lines were used. For the gene targeting method, electroporation or lipofection was carried out as described before 4 . In brief, for electroporation, ~ 1-5 × 10 6 comp-hPSCs suspended in PBS were mixed with targeting vector and CRISPR-Cas9 plasmid and transferred to a Gene Pulser cuvette (Bio-Rad). Electroporation was carried out using Gene Pulser equipment (Bio-Rad). For lipofection, reverse transfection was carried out. 2 × 10 5 comp-hPSCs were suspended in 100-200 μ l of Opti-MEM containing targeting vector, CRISPR-Cas9 plasmid and lipofectamine 2000 (Thermo Scientific) complex, and left for 5 min at room temperature. After electroporation or lipofection, PSCs were seeded onto 4 drug resistant (DR4) MEF (GlobalStem or SCI) and 48 h later, 0.5 μ g ml −1 puromycine (Sigma) was added to the culture medium for selection. After the selection, puromycin-resistant hPSC colonies were judged to be correctly targeted by PCR using following primers (primer forward 1, 5′ -GGGGCCAGTCTAACTAGGTGTG-3′ ; primer reverse 1, 5′ -GGTCTTCCTGGAAATCCAGCCG-3′ ; primer reverse 2, 5′ -TGCCGGTGCCATGCCCCAGGAACA-3′ , see Extended Data Fig. 4a, b) . The targeted clones were expanded and then used for excision of rox-flanked PGK-PuroΔ tk by transient transfection of pCAG-Dre-IRES-Hygromycinr. After selection with 25 μ g ml −1 hygromycin B and subsequently with 0.2 μ M FIAU, colonies were picked up and the excision judged by adding puromycin or PCR using following primers (primer forward 2, 5′ -CCGTCCCATGCACGTCTTTATC-3′ ; primer forward 3, 5′ -GAGGGCAGAGGAAGTCTGCTAACA-3′ ; primer reverse 3, 5′ -GGTCTTCCTGGAAATCCAGCCG-3′ ; see Extended Data Fig. 4a, b) . In the representative clone derived from Wis2 hESC used in this study, G-banding karyotype analysis was performed at Medical Genetics Laboratories, Cambridge University Hospitals NHS Foundation Trust following their standard protocols, and the normal karyotypes were confirmed (20 out of 20 cells). All clones showed correlation of NANOS3-tdTomato and TNAP expression by FACS analysis (representatives are shown in Extended Data Fig. 4d-f) . We also confirmed that NANOS3-tdTomato + cells specifically expressed the other PGC markers by immunostaining (Extended Data Fig. 4g) . Notably, fluorescence of NANOS-tdTomato was brighter than NANOS3-mCherry, which we reported previously 4 (Extended Data Fig. 4h ).
For gene introduction using PiggyBAC system, reverse transfection was carried out. 2 × 10 5 SOX17-knockout comp-hPSCs, NANOS3-tdTomato comp-hPSCs were suspended in 100-200 μ l of Opti-MEM containing plasmids and lipofectamine 2000 (Thermo Scientific) complex, and left for 5 min at room temperature. The cells were seeded on DR4 MEF at several different concentrations, and then 48 h later, drugs for selection were added to the culture medium. Quantitative reverse transcription PCR. Total RNA was extracted using PicoPure RNA Isolation Kit (Thermo Fisher Scientific) and cDNA was synthesized using QuantiTect Reverse Transcription Kit (QIAGEN) according to manufacturer's protocols. RT-qPCR was performed and analysed as described previously 39 and the primers sequences used in the paper are listed in Supplementary Table 3 . Values normalized to GAPDH and relative to control samples (comp-hPSCs or hPGCs) are shown in the figures. Error bars are mean ± s.d. from technical triplicates with two experiments. Immunofluorescence staining of cells and cryo-section of embryoids. Cells were cultured on μ -Slide 8 well (ibidi) and fixed in 4% PFA for 10 min at room temperature. Embryoids were fixed in 4% PFA for 2-4 h or overnight at 4 °C and embedded in OCT compound for frozen sections. Each sample was incubated with primary antibodies for 1-2 h at room temperature or overnight in a cold room and with fluorescent-conjugated secondary antibodies for 1 h at room temperature. Antibodies used here are listed on Supplementary Table 2. After antibody treatment, samples were stained with DAPI (Sigma) to mark nuclei and were observed under confocal laser scanning microscopy. Flow cytometry analysis. PSCs, embryoids, definitive endoderm and lateral mesoderm were trypsinized with 0.25% trypsin/EDTA at 37 °C for 5-15 min and stained with Alexa-488 or 647 conjugated anti-TNAP antibody (BD Bioscience), PerCP-Cy5.5 conjugated anti-CXCR4 antibody (Biolegend), PE-Cy7 conjugated anti-PDGFRa antibody (Biolegend) and/or Alexa-647 conjugated anti-CD38 antibody and subjected to FACS LSR Frotessa cytometry (BD Bioscience). FACS data were analysed by Flowjo software. Western blot analysis. Western blot analysis was carried out as described before 4 . Briefly, whole-cell extracts were prepared from day 4 embryoids in lysis buffer composed of 50 mM Tris-HCl (pH 7.5), 0.15M NaCl, 0.1% SDS, 1% Triton X-100, 1% sodium deoxycholate and complete mini EDTA free protease inhibitor cocktail (Roche Applied Science). After electrophoresis, proteins were transferred to nitrocellulose membranes. Membranes were incubated in Western Blocking Reagent (Roche Applied Science) and treated with antibodies. Primary antibodies against SOX17 (goat IgG; R&D systems, see Supplementary Table 2) , and H3 (rabbit IgG; Abcam ab1791) were used. Horseradish peroxidase-conjugated secondary antibodies against goat or mouse IgG were added (Dako, Life Technologies). After antibody treatment, blots were developed using ECL Western Blotting Detection System (GE Healthcare). Preparation of RNA-sequencing libraries. Total RNA (5 ng) was reversetranscribed and amplified into cDNA using Ovation RNA-Seq System V2 (Nugen). Amplified cDNA was sonicated into 250 bp by Covaris S220 Focusedultrasonicators. Subsequently, RNASeq library was generated with 500 ng of fragmented cDNA using Ovation Rapid DR Multiplex System (Nugen). Libraries were quantified by qPCR using KAPA Library Quantification Kit (Kapa Biosystems). Libraries were subjected to single-end 50 bp sequencing on HiSeq 2500 sequencing system (Illumina). Every four indexed libraries were multiplexed to one lane of a flowcell, resulting in > 40 million single-end reads per sample Bioinfomatics analysis. Adapter-and quality-trimmed RNA-seq reads were mapped to the human reference genomes (UCSC GRCh37/hg19) using TopHat2 (http://ccb.jhu.edu/software/tophat, version: 2.0.13) guided by ENSEMBL 83 gene models. Raw counts per transcripts were obtained using featureCounts, only the longest transcript per gene was kept. Replicates were evaluated, raw counts were normalized, and the differential expression of transcripts was statistically evaluated by the R Bioconductor DESeq2 package (http://www.bioconductor.org). Expression-normalized transcript counts were further normalized by transcript length (per kB). Transcript annotations in all bioinformatics analyses were based on ENSEMBL (Release 83) considering protein coding, long-noncoding RNA and 
